Clinical Trial Update: Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada

View source ↗

Summary

A post-marketing safety study of Cervarix (HPV vaccine) in the United States and Canada has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Status: TERMINATED